Singapore markets open in 4 hours 6 minutes

Straits Times Index
3,190.71
-34.64(-1.07%)
S&P 500
3,900.79
-22.89(-0.58%)
Dow
31,253.13
-236.94(-0.75%)
Nasdaq
11,388.50
-29.66(-0.26%)
BTC-USD
30,140.63
+978.78(+3.36%)
CMC Crypto 200
669.81
+17.58(+2.69%)

Singapore wants to keep borders open even If variant emerges

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

58.43

+6.32

(+12.13%)

At close: 04:00PM EDT

58.59

+0.16

(+0.27%)

After hours:

04:52PM EDT

Trade prices are not sourced from all markets

All

Motley Fool
Will Novavax Stock Ever Reach Its All-Time High Again?
Novavax (NASDAQ: NVAX) investors are no strangers to tragedy. On Feb. 9 in 2021, shares of the coronavirus vaccine developer hit their all-time high of $331.68. Are longtime shareholders doomed to heavy losses forever, or will Novavax return to its glory days?
Motley Fool
4 Growth Stocks Billionaire Money Managers Piled Into During the First Quarter
A turbulent market didn't scare successful money managers away from buying shares in these fast-paced companies.
Motley Fool
Could Novavax's Next Step Make It a Multibagger?
Novavax disappointed investors when its regulatory submissions fell behind. Now, all eyes are on Novavax's next step: winning authorization in the U.S. Could this nudge the stock out of its slump -- and even turn it into a multibagger? Novavax reported revenue of $704 million and net income of $203 million.